PTC
NVO

Private Trust Company’s Novo Nordisk NVO Stock Holding History

Private Trust Company’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Buy
4,634
+105
+2% +$4.51K 0.02% 776
2026
Q1 		$166K Sell
4,529
-1,154
-20% -$54.7K 0.01% 847
2025
Q4 		$289K Sell
5,683
-6,521
-53% -$333K 0.03% 615
2025
Q3 		$677K Sell
12,204
-9,744
-44% -$570K 0.06% 340
2025
Q2 		$1.51M Sell
21,948
-5,489
-20% -$373K 0.14% 154
2025
Q1 		$1.91M Sell
27,437
-1,161
-4% -$95.9K 0.2% 112
2024
Q4 		$2.46M Sell
28,598
-1,259
-4% -$136K 0.25% 81
2024
Q3 		$3.56M Sell
29,857
-2,094
-7% -$279K 0.36% 55
2024
Q2 		$4.56M Sell
31,951
-905
-3% -$120K 0.49% 33
2024
Q1 		$4.22M Buy
32,856
+3,047
+10% +$363K 0.46% 37
2023
Q4 		$3.08M Buy
29,809
+305
+1% +$30.2K 0.36% 53
2023
Q3 		$2.68M Sell
29,504
-598
-2% -$52.7K 0.35% 56
2023
Q2 		$2.44M Buy
30,102
+1,246
+4% +$102K 0.31% 70
2023
Q1 		$2.3M Buy
28,856
+26
+0.1% +$1.84K 0.31% 73
2022
Q4 		$1.95M Buy
28,830
+23,082
+402% +$1.35M 0.29% 72
2022
Q3 		$286K Sell
5,748
-10
-0.2% -$536 0.05% 401
2022
Q2 		$321K Sell
5,758
-286
-5% -$15.9K 0.05% 379
2022
Q1 		$336K Buy
6,044
+1,552
+35% +$79.7K 0.05% 283
2021
Q4 		$252K Buy
+4,492
New +$243K 0.03% 347
2019
Q2 		– Sell
-11,384
Closed -$297K – 379
2019
Q1 		$297K Buy
11,384
+818
+8% +$20.1K 0.06% 295
2018
Q4 		$243K Sell
10,566
-1,154
-10% -$25.6K 0.06% 306
2018
Q3 		$276K Sell
11,720
-284
-2% -$6.93K 0.06% 313
2018
Q2 		$276K Sell
12,004
-1,074
-8% -$25.5K 0.06% 305
2018
Q1 		$322K Buy
13,078
+2,184
+20% +$57.3K 0.07% 292
2017
Q4 		$292K Buy
10,894
+1,094
+11% +$27.8K 0.06% 302
2017
Q3 		$235K Hold
9,800
– – 0.05% 336
2017
Q2 		$210K Buy
+9,800
New +$198K 0.05% 344
2017
Q1 		– Sell
-12,296
Closed -$220K – 367
2016
Q4 		$220K Sell
12,296
-12,160
-50% -$220K 0.05% 294
2016
Q3 		$508K Sell
24,456
-1,814
-7% -$45K 0.12% 196
2016
Q2 		$706K Buy
26,270
+2,060
+9% +$56.5K 0.18% 138
2016
Q1 		$655K Buy
24,210
+4,940
+26% +$132K 0.18% 142
2015
Q4 		$559K Buy
19,270
+722
+4% +$20K 0.16% 165
2015
Q3 		$503K Buy
18,548
+1,856
+11% +$52.5K 0.15% 176
2015
Q2 		$457K Sell
16,692
-426
-2% -$12K 0.13% 203
2015
Q1 		$456K Buy
17,118
+1,000
+6% +$23K 0.13% 199
2014
Q4 		$341K Buy
16,118
+1,030
+7% +$23K 0.11% 219
2014
Q3 		$359K Sell
15,088
-790
-5% -$18.2K 0.12% 198
2014
Q2 		$367K Buy
15,878
+12,936
+440% +$286K 0.12% 200
2014
Q1 		$67K Sell
2,942
-128
-4% -$2.73K 0.03% 430
2013
Q4 		$57K Buy
3,070
+750
+32% +$13.1K 0.02% 432
2013
Q3 		$39K Sell
2,320
-60
-3% -$1.01K 0.02% 483
2013
Q2 		$37K Buy
+2,380
New +$39.6K 0.02% 473

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Private Trust Company's NVO Position: Q2 2026 in Review

Private Trust Company increased its Novo Nordisk (NVO) stake by 2.3% in Q2 2026, buying an estimated $4.51K and bringing the position to 4,634 shares worth $222K. The position accounts for 0.02% of the portfolio, ranked #776.

Private Trust Company first reported a position in NVO in Q2 2013 and has held it in 42 quarters since. The position peaked at $4.56M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Private Trust Company held 4,634 shares of Novo Nordisk worth $222K as of Q2 2026.
  • Private Trust Company bought 105 Novo Nordisk shares in Q2 2026, an estimated $4.51K.
  • Novo Nordisk made up 0.02% of Private Trust Company's portfolio in Q2 2026, its #776 holding.
  • Private Trust Company first reported a position in Novo Nordisk in Q2 2013 and has held it in 42 quarters since.
  • Private Trust Company's Novo Nordisk position peaked at $4.56M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.